Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 2
1964 1
1974 33
1975 51
1976 40
1977 41
1978 44
1979 34
1980 45
1981 44
1982 38
1983 20
1984 30
1985 15
1986 22
1987 25
1988 23
1989 26
1990 27
1991 18
1992 33
1993 31
1994 30
1995 28
1996 33
1997 49
1998 35
1999 103
2000 65
2001 77
2002 83
2003 133
2004 136
2005 168
2006 204
2007 176
2008 245
2009 276
2010 537
2011 930
2012 1331
2013 1336
2014 2099
2015 2830
2016 3479
2017 3318
2018 3514
2019 2917
2020 3036
2021 3133
2022 2731
2023 2685
2024 3593
2025 231

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36,368 results

Results by year

Filters applied: . Clear all
Page 1
Treatment of refractory thyroid cancer.
Berdelou A, Lamartina L, Klain M, Leboulleux S, Schlumberger M. Berdelou A, et al. Endocr Relat Cancer. 2018 Apr;25(4):R209-R223. doi: 10.1530/ERC-17-0542. Epub 2018 Jan 25. Endocr Relat Cancer. 2018. PMID: 29371330 Review.
Thyroid cancer in the age of COVID-19.
Tsang VHM, Gild M, Glover A, Clifton-Bligh R, Robinson BG. Tsang VHM, et al. Endocr Relat Cancer. 2020 Nov;27(11):R407-R416. doi: 10.1530/ERC-20-0279. Endocr Relat Cancer. 2020. PMID: 32810844 Review.
Mechanisms of RET-mediated signal transduction.
Carlomagno F, Moccia M, Federico G, Santoro M. Carlomagno F, et al. Endocr Relat Cancer. 2024 Dec 13;32(1):e240131. doi: 10.1530/ERC-24-0131. Print 2025 Jan 1. Endocr Relat Cancer. 2024. PMID: 39413211 Review.
Molecular underpinnings of enzalutamide resistance.
Prekovic S, van den Broeck T, Linder S, van Royen ME, Houtsmuller AB, Handle F, Joniau S, Zwart W, Claessens F. Prekovic S, et al. Endocr Relat Cancer. 2018 Nov 1;25(11):R545–R557. doi: 10.1530/ERC-17-0136. Endocr Relat Cancer. 2018. PMID: 30306781
Fibroblast growth factors signaling in bone metastasis.
Labanca E, Vazquez ES, Corn PG, Roberts JM, Wang F, Logothetis CJ, Navone NM. Labanca E, et al. Endocr Relat Cancer. 2020 Jul;27(7):R255-R265. doi: 10.1530/ERC-19-0472. Endocr Relat Cancer. 2020. PMID: 32369771 Free PMC article. Review.
Mechanisms of resistance to RET-directed therapies.
Clifton-Bligh RJ. Clifton-Bligh RJ. Endocr Relat Cancer. 2025 Jan 10;32(2):e240224. doi: 10.1530/ERC-24-0224. Print 2025 Feb 1. Endocr Relat Cancer. 2025. PMID: 39655713 Review.
Building on strength.
Ringel MD. Ringel MD. Endocr Relat Cancer. 2021 Jan;28(1):E1-E2. doi: 10.1530/ERC-20-0427. Endocr Relat Cancer. 2021. PMID: 33393936 No abstract available.
36,368 results
You have reached the last available page of results. Please see the User Guide for more information.